American Association of Individual Investors1d
Which Is a Better Investment, Arrowhead Pharmaceuticals, Inc. or Veracyte, Inc. Stock?
Learn more about whether Arrowhead Pharmaceuticals, Inc. or Veracyte, Inc. is a better investment based on AAII's A+ Investor ...
Genelux Brings in Arrowhead Pharmaceuticals Exec as New Finance Chief
Genelux named Matthew Pulisic as chief financial officer.
2,020 Shares in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Purchased by R Squared Ltd
R Squared Ltd acquired a new stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The ...
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Receives “Buy” Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research ...
Arrowhead Pharmaceuticals' SWOT analysis: stock poised for potential breakthrough
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), a biopharmaceutical company with a market capitalization of $2.68 billion ...
BioSpace1d
The Top 7 Biopharma Licensing Deals of 2024
Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...
RBC Capital Remains a Buy on Arrowhead Pharmaceuticals (ARWR)
In a report released today, Luca Issi from RBC Capital maintained a Buy rating on Arrowhead Pharmaceuticals (ARWR – Research Report), with a ...
Genelux names Matthew Pulisic as CFO, effective January 30
Genelux (GNLX) announced that Matthew Pulisic has joined the company as its new CFO, effective January 30. Most recently, Pulisic served as ...
EurekAlert!1d
Cystic fibrosis damages the immune system early on
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...